Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,886,622
+$645,113 QoQ
Shares Held
16,256
+9.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#761
of 3,139 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MUFG SECURITIES AMERICAS INC. holds $89,189,559 across 9 Drug Manufacturers - General names. AMGN ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
23,826 | $28,577,621 | |
| 2 | JNJ |
Johnson & Johnson
|
72,502 | $18,413,332 | |
| 3 | ABBV |
AbbVie Inc.
|
53,213 | $13,390,519 | |
| 4 | MRK |
Merck & Co., Inc.
|
74,388 | $9,558,858 | |
| 5 | AMGN |
Amgen Inc
This page
|
16,256 | $5,886,622 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
37,394 | $4,724,357 | |
| 7 | PFE |
Pfizer Inc
|
171,660 | $4,133,572 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
61,504 | $3,543,860 |
All Filings in AMGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,886,622 | 16,256 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,241,509 | 14,897 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,748,286 | 14,507 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,096,979 | 14,518 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,327,345 | 11,917 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,962,528 | 9,509 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,068,439 | 7,936 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||